IP25-03: Outcomes in Men with Palpable Prostate Cancer with Normal Range Prostate Specific Antigen

IP25-03: Outcomes in Men with Palpable Prostate Cancer with Normal Range Prostate Specific Antigen

Saturday, May 16, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
145AB
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!